Mymetics Corporation
MYMX · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | -0.57 | 76.40 | 113.50 |
| FCF Yield | -0.03% | -0.00% | -0.00% | -0.00% |
| EV / EBITDA | -2,622.29 | -1,799.74 | -14,536.32 | -85,891.76 |
| Quality | ||||
| ROIC | 83.01% | 230.95% | -18.90% | -6.86% |
| Gross Margin | -62.22% | -4.97% | -19,866.67% | -112.40% |
| Cash Conversion Ratio | 0.30 | 0.08 | 0.26 | 0.35 |
| Growth | ||||
| Revenue 3-Year CAGR | 12.74% | 35.74% | 155.18% | 179.87% |
| Free Cash Flow Growth | 44.54% | -26.36% | -48.93% | 40.78% |
| Safety | ||||
| Net Debt / EBITDA | -187.15 | -10.60 | -62.68 | -360.22 |
| Interest Coverage | -0.54 | -0.41 | -1.72 | -0.69 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 3,350,074,490,880,000.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -806.87 | -285.38 | 2,434.11 | -29.22 |